These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32678225)

  • 21. Analysis of potential biomarkers of estrogen-initiated cancer in the urine of Syrian golden hamsters treated with 4-hydroxyestradiol.
    Todorovic R; Devanesan P; Higginbotham S; Zhao J; Gross ML; Rogan EG; Cavalieri EL
    Carcinogenesis; 2001 Jun; 22(6):905-11. PubMed ID: 11375897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer.
    Rogan EG; Badawi AF; Devanesan PD; Meza JL; Edney JA; West WW; Higginbotham SM; Cavalieri EL
    Carcinogenesis; 2003 Apr; 24(4):697-702. PubMed ID: 12727798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides.
    Stack DE; Byun J; Gross ML; Rogan EG; Cavalieri EL
    Chem Res Toxicol; 1996; 9(5):851-9. PubMed ID: 8828920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The molecular etiology of breast cancer: evidence from biomarkers of risk.
    Gaikwad NW; Yang L; Muti P; Meza JL; Pruthi S; Ingle JN; Rogan EG; Cavalieri EL
    Int J Cancer; 2008 May; 122(9):1949-57. PubMed ID: 18098283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of serum estrogen-DNA adducts as potential biomarkers for breast cancer risk.
    Pruthi S; Yang L; Sandhu NP; Ingle JN; Beseler CL; Suman VJ; Cavalieri EL; Rogan EG
    J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):73-9. PubMed ID: 22386952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma.
    Singh S; Chakravarti D; Edney JA; Hollins RR; Johnson PJ; West WW; Higginbotham SM; Cavalieri EL; Rogan EG
    Oncol Rep; 2005 Oct; 14(4):1091-6. PubMed ID: 16142378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of multiplex endogenous estrogen metabolites in human urine using ultra-fast liquid chromatography-tandem mass spectrometry: a case study for breast cancer.
    Huang J; Sun J; Chen Y; Song Y; Dong L; Zhan Q; Zhang R; Abliz Z
    Anal Chim Acta; 2012 Jan; 711():60-8. PubMed ID: 22152797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critical depurinating DNA adducts: Estrogen adducts in the etiology and prevention of cancer and dopamine adducts in the etiology and prevention of Parkinson's disease.
    Cavalieri EL; Rogan EG; Zahid M
    Int J Cancer; 2017 Sep; 141(6):1078-1090. PubMed ID: 28388839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel biomarkers for risk of prostate cancer: results from a case-control study.
    Yang L; Gaikwad NW; Meza J; Cavalieri EL; Muti P; Trock B; Rogan EG
    Prostate; 2009 Jan; 69(1):41-8. PubMed ID: 18816637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urine biomarkers of risk in the molecular etiology of breast cancer.
    Gaikwad NW; Yang L; Pruthi S; Ingle JN; Sandhu N; Rogan EG; Cavalieri EL
    Breast Cancer (Auckl); 2009 Jan; 3():1-8. PubMed ID: 21556245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic activation and formation of DNA adducts of hexestrol, a synthetic nonsteroidal carcinogenic estrogen.
    Jan ST; Devanesan PD; Stack DE; Ramanathan R; Byun J; Gross ML; Rogan EG; Cavalieri EL
    Chem Res Toxicol; 1998 May; 11(5):412-9. PubMed ID: 9585471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.
    Dorgan JF; Longcope C; Stephenson HE; Falk RT; Miller R; Franz C; Kahle L; Campbell WS; Tangrea JA; Schatzkin A
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):533-9. PubMed ID: 8827358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and structure elucidation of estrogen quinones conjugated with cysteine, N-acetylcysteine, and glutathione.
    Cao K; Stack DE; Ramanathan R; Gross ML; Rogan EG; Cavalieri EL
    Chem Res Toxicol; 1998 Aug; 11(8):909-16. PubMed ID: 9705753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formation of epoxide and quinone protein adducts in B6C3F1 mice treated with naphthalene, sulfate conjugate of 1,4-dihydroxynaphthalene and 1,4-naphthoquinone.
    Tsuruda LS; Lamé MW; Jones AD
    Arch Toxicol; 1995; 69(6):362-7. PubMed ID: 7495373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectral characterization of catechol estrogen quinone (CEQ)-derived DNA adducts and their identification in human breast tissue extract.
    Markushin Y; Zhong W; Cavalieri EL; Rogan EG; Small GJ; Yeung ES; Jankowiak R
    Chem Res Toxicol; 2003 Sep; 16(9):1107-17. PubMed ID: 12971798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p-Quinone methides are the major decomposition products of catechol estrogen o-quinones.
    Bolton JL; Shen L
    Carcinogenesis; 1996 May; 17(5):925-9. PubMed ID: 8640939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA.
    Zhang Y; Gaikwad NW; Olson K; Zahid M; Cavalieri EL; Rogan EG
    Metabolism; 2007 Jul; 56(7):887-94. PubMed ID: 17570247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mass spectrometry evidence for formation of estrogen-homocysteine conjugates: estrogens can regulate homocysteine levels.
    Gaikwad NW
    Free Radic Biol Med; 2013 Dec; 65():1447-1454. PubMed ID: 23928335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and characterization of estrogen 2,3- and 3,4-quinones. Comparison of DNA adducts formed by the quinones versus horseradish peroxidase-activated catechol estrogens.
    Dwivedy I; Devanesan P; Cremonesi P; Rogan E; Cavalieri E
    Chem Res Toxicol; 1992; 5(6):828-33. PubMed ID: 1336990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formation of the depurinating N3adenine and N7guanine adducts by reaction of DNA with hexestrol-3',4'-quinone or enzyme-activated 3'-hydroxyhexestrol. Implications for a unifying mechanism of tumor initiation by natural and synthetic estrogens.
    Saeed M; Gunselman SJ; Higginbotham S; Rogan E; Cavalieri E
    Steroids; 2005 Jan; 70(1):37-45. PubMed ID: 15610895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.